Hyderabad: India’s largest pharma player Sun Pharma is exploring the possibility of setting up manufacturing facilities at the upcoming Pharma City, Sun Pharma founder and managing director Dilip Shanghvi told.
“We are evaluating all the facilities that they (Telangana government) are offering and which kind of products that we can produce here,” he said on the sidelines of BioAsia 2020.
Shanghvi said the company is exploring opportunities for manufacturing in Telangana for both, domestic market as well as exports.
Pointing out that the company is betting big on innovation, he said Sun Pharma plans to launch, over the next five years, at least a couple of innovative new drugs.
Also read: Sun Pharma launches acne management capsules
Stating that not a single drug has been discovered in India for the global markets, Shangvi said while globally about $200 billion is spent by the pharma industry on R&D, companies in India spend around 1-1.5% of this money on R&D.